Stock Earnings

Question 1

What are Ironwood Pharmaceuticals Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Ironwood Pharmaceuticals Inc has a total asset of $350, Net loss of $0

Question 2

What are the key financial ratios for IRWD?

Accepted Answer

Ironwood Pharmaceuticals Inc's Current ratio is 0.53, has a Net margin is 0, sales per share of $2.19.

Question 3

How is Ironwood Pharmaceuticals Inc's revenue broken down by segment or geography?

Accepted Answer

Ironwood Pharmaceuticals Inc largest revenue segment is Human Therapeutics, at a revenue of 351,410,000 in the most earnings release.For geography, United States is the primary market for Ironwood Pharmaceuticals Inc, at a revenue of 341,219,110.

Question 4

Is Ironwood Pharmaceuticals Inc profitable?

Accepted Answer

no, according to the latest financial statements, Ironwood Pharmaceuticals Inc has a net loss of $0

Question 5

Does Ironwood Pharmaceuticals Inc have any liabilities?

Accepted Answer

yes, Ironwood Pharmaceuticals Inc has liability of 652

Question 6

How many outstanding shares for Ironwood Pharmaceuticals Inc?

Accepted Answer

Ironwood Pharmaceuticals Inc has a total outstanding shares of 160.2

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	338	351	442	410	413	389
Revenue Growth (YoY)	-11%	-21%	8%	-1%	6%	-9%
Cost of Revenue	--	--	--	0	0	3
Gross Profit	--	--	--	410	413	386
Selling, General & Admin	96	144	158	115	111	141
Research & Development	98	111	116	44	70	88
Operating Expenses	195	255	274	160	181	229
Other Non Operating Income (Expenses)	0	0	--	0	0	0
Pretax Income	93	65	-948	252	200	108
Income Tax Expense	65	64	83	77	-327	2
Net Income	28	0	-1,002	175	528	106
Net Income Growth	-1,500%	-100%	-673%	-67%	398%	405%
Shares Outstanding (Diluted)	177.76	160.08	155.43	186.31	164.41	160.7
Shares Change (YoY)	11%	3%	-17%	13%	2%	3%
EPS (Diluted)	0.16	0	-6.44	0.93	3.21	0.66
EPS Growth	-1,100%	-100%	-793%	-71%	387%	408%
Free Cash Flow	67	103	-842	273	261	167
Free Cash Flow Per Share	0.37	0.64	-5.41	1.46	1.58	1.03
Gross Margin	--	--	--	100%	100%	99.22%
Operating Margin	42.3%	27.06%	38%	60.97%	56.17%	40.1%
Profit Margin	8.28%	0%	-226.69%	42.68%	127.84%	27.24%
Free Cash Flow Margin	19.82%	29.34%	-190.49%	66.58%	63.19%	42.93%
EBITDA	144	97	169	251	233	159
EBITDA Margin	42.6%	27.63%	38.23%	61.21%	56.41%	40.87%
D&A For EBITDA	1	2	1	1	1	3
EBIT	143	95	168	250	232	156
EBIT Margin	42.3%	27.06%	38%	60.97%	56.17%	40.1%
Effective Tax Rate	69.89%	98.46%	-8.75%	30.55%	-163.5%	1.85%

Ironwood Pharmaceuticals Inc (IRWD) Price

IRWD Stock Price Chart

IRWD Income

Follow-Up Questions